Relief Therap 
Welcome,         Profile    Billing    Logout  
 3 Products   36 Diseases   3 Products   4 Trials   668 News 


«123456»
  • ||||||||||  Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NRx Pharma
    Trial completion date, Trial initiation date, Trial primary completion date:  AVINALI: Inhaled ZYESAMI (clinicaltrials.gov) -  Oct 29, 2020   
    P2/3,  N=288, Not yet recruiting, 
    Initiation date: Sep 2020 --> Jan 2021 Trial completion date: Nov 2020 --> Aug 2021 | Initiation date: Jul 2020 --> Dec 2020 | Trial primary completion date: Oct 2020 --> Jun 2021
  • ||||||||||  Zyesami IV (aviptadil intravenous) / Relief Therap, NRx Pharma
    Trial completion date, Trial primary completion date:  COVID-AIV: Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure (clinicaltrials.gov) -  Oct 29, 2020   
    P2,  N=144, Recruiting, 
    Trial completion date: Nov 2020 --> Aug 2021 | Initiation date: Jul 2020 --> Dec 2020 | Trial primary completion date: Oct 2020 --> Jun 2021 Trial completion date: Sep 2020 --> Feb 2021 | Trial primary completion date: Aug 2020 --> Dec 2020
  • ||||||||||  aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
    #Aviptadil #RLF100 (Twitter) -  Sep 26, 2020   
  • ||||||||||  aviptadil (DK-1000) / Relief Therap, United Therapeutics, Seren Clinical, NeuroRx
    @US_FDA what about RLF-100? (Twitter) -  Sep 23, 2020   
  • ||||||||||  Zyesami inhalation (aviptadil) / Relief Therap, United Therapeutics Corp, Seren Clinical, NRx Pharma
    Trial completion date:  Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS (clinicaltrials.gov) -  Sep 20, 2020   
    P1,  N=80, Not yet recruiting, 
    Trial completion date: Sep 2020 --> Feb 2021 | Trial primary completion date: Aug 2020 --> Dec 2020 Trial completion date: Dec 2021 --> Mar 2022